Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

GENENTECH, INC.

SOUTH SAN FRANCISCO, CA US

1. 20110047103 ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF PREVIOUSLY TREATED BREAST CANCER 02-24-2011
2. 20110046066 INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds 02-24-2011
3. 20110044977 Subcutaneous anti-HER2 antibody formulations and uses thereof 02-24-2011
4. 20110039324 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS 02-17-2011
5. 20110028348 BINDING POLYPEPTIDES WITH OPTIMIZED SCAFFOLDS 02-03-2011
6. 20110027275 INHIBITION OF TUMOR METASTASIS - generally to the inhibition of angiogenesis and tumor metastasis 02-03-2011
7. 20110021496 THIENOPYRIMIDINE DERIVATIVES AS P13K INHIBITORS 01-27-2011
8. 20110020322 CRYSTALLIZATION OF ANTI-CD20 ANTIBODIES - generally to crystalline forms of anti-CD20 antibodies and purification of anti-CD20 antibodies involving 01-27-2011
9. 20110020300 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF GLUCOCORTICOID RECEPTOR (GCR) GENES 01-27-2011
10. 20110014194 METHODS FOR INHIBITING ANGIOGENESIS USING EGFL8 ANTAGONISTS 01-20-2011
11. 20100331305 OXO-HETEROCYCLE FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE 12-30-2010
12. 20100331251 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 12-30-2010
13. 20100330096 METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES 12-30-2010
14. 20100330082 NLRR-1 ANTAGONISTS AND USES THEREOF - NLRR-1 antagonists and methods of their use in treating cancer and other disorders are provided 12-30-2010
15. 20100322935 Tri- or Tetraspecific Antibodies - , their manufacture and use 12-23-2010
16. 20100317643 JANUS KINASE INHIBITOR COMPOUNDS AND METHODS 12-16-2010
17. 20100316652 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 12-16-2010
18. 20100316639 BIOMARKERS FOR IGF-1R INHIBITOR THERAPY - The invention concerns the identification and validation of certain biomarkers for selecting patients for 12-16-2010
19. 20100310581 COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) 12-09-2010
20. 20100305096 BICYCLIC PYRIMIDINE PI3K INHIBITOR COMPOUNDS SELECTIVE FOR P110 DELTA, AND METHODS OF USE 12-02-2010
21. 20100305084 BICYCLIC INDOLE-PYRIMIDINE PI3K INHIBITOR COMPOUNDS SELECTIVE FOR P110 DELTA, AND METHODS OF USE 12-02-2010
22. 20100303810 METHOD FOR TREATING LUPUS - method of treating lupus in a subject eligible for treatment is provided involving administering an effective amount of an 12-02-2010
23. 20100292468 PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS 11-18-2010
24. 20100292312 ANTI-DLL4 ANTIBODIES AND METHODS USING SAME 11-18-2010
25. 20100291114 Crystal structures and methods using same 11-18-2010
26. 20100291072 ANTIBODY VARIANTS WITH FASTER ANTIGEN ASSOCIATION RATES 11-18-2010
27. 20100285010 TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY 11-11-2010
28. 20100285009 HUMANIZED ANTI-EGFL7 ANTIBODIES AND METHODS USING SAME 11-11-2010
29. 20100280063 8-ANILINOIMIDAZOPYRIDINES AND THEIR USE AS ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS 11-04-2010
30. 20100279298 Methods and Compositions For Detecting Autoimmune Disorders 11-04-2010
31. 20100278842 ANTI-EPHB2 ANTIBODIES AND METHODS USING SAME 11-04-2010
32. 20100273257 Apo-2DcR - Novel polypeptides, designated Apo-2DcR, which are capable of binding Apo-2 ligand are provided 10-28-2010
33. 20100272738 ANTI-OX40L ANTIBODIES AND METHODS USING SAME 10-28-2010
34. 20100269184 Apo-2DcR - Novel polypeptides, designated Apo-2DcR, which are capable of binding Apo-2 ligand are provided 10-21-2010
35. 20100267050 METHODS AND COMPOSITIONS FOR TARGETING POLYUBIQUITIN 10-21-2010
36. 20100267033 Methods and Compositions For Detecting Autoimmune Disorders 10-21-2010
37. 20100266698 USE OF INSULIN FOR THE TREATMENT OF CARTILAGINOUS DISORDERS 10-21-2010
38. 20100266593 WNT ANTAGONISTS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF WNT-MEDIATED DISORDERS 10-21-2010
39. 20100266589 ADJUVANT CANCER THERAPY - Disclosed herein are methods and compostions comprising anti-VEGF antibodies for use in adjuvant cancer therapy 10-21-2010
40. 20100261888 Recombinant Production of Heparin Binding Proteins 10-14-2010
41. 20100260782 NOVEL ANTI- Alpha 5 Beta 1 ANTIBODIES AND USES THEREOF 10-14-2010
42. 20100256115 INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds 10-07-2010
43. 20100255515 ELISA FOR VEGF - The vascular endothelial growth factor activity in a patient's bloodstream or other biological sample can serve as a diagnostic and 10-07-2010
44. 20100255508 USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS 10-07-2010
45. 20100255010 ANTI-HER ANTIBODIES - The invention provides anti-HER antibodies including multispecific anti-HER antibodies compositions comprising and methods of 10-07-2010
46. 20100247531 ANTI-FGFR3 ANTIBODIES AND METHODS USING SAME 09-30-2010
47. 20100247430 Methods and Compositions for Modulating T Cells 09-30-2010
48. 20100239567 Antibody Formulation - formulation comprising a therapeutically effective amount of an antibody optionally not subjected to prior lyophilization 09-23-2010
49. 20100233164 COMBINATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF HEMATOPOIETIC MALIGNANCIES 09-16-2010
50. 20100233153 NOVEL GENE DISRUPTIONS, COMPOSITIONS AND THE METHODS RELATING THERETO 09-16-2010
51. 20100233121 METHOD FOR TREATING MULTIPLE SCLEROSIS - Methods for treating multiple sclerosis with a CD20 antibody using special dosing regimens and protocols are 09-16-2010
52. 20100226880 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 09-09-2010
53. 20100221262 ANTI-UNC5B ANTIBODIES AND METHODS OF USE 09-02-2010
54. 20100221176 METHODS AND COMPOSITIONS FOR PROTEIN LABELLING 09-02-2010
55. 20100216768 N-SUBSTITUTED AZAINDOLES AND METHODS OF USE 08-26-2010
56. 20100216115 METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS 08-26-2010
57. 20100210826 HGF BETA CHAIN VARIANTS - The invention provides HGF/Met modulators comprising HGF having mutations in regions that affect HGF function 08-19-2010
58. 20100209956 METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION 08-19-2010
59. 20100203056 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION 08-12-2010
60. 20100203044 DR6 ANTAGONISTS AND USES THEREOF IN TREATING NEUROLOGICAL DISORDERS 08-12-2010
61. 20100203041 ANTIBODIES TO EGFL7 AND METHODS FOR THEIR USE 08-12-2010
62. 20100190769 THIAZOLOPYRIMIDINES AND THEIR USE AS INHIBITORS OF PHOSPHATIDYLINOSITOL-3 KINASE 07-29-2010
63. 20100189660 METHODS FOR THE DETECTION OF FATTY-ACYLATED PROTEIN 07-29-2010
64. 20100166749 Polypeptide variants with altered effector function 07-01-2010
65. 20100162415 TRANSGENIC MICE EXPRESSING HUMANIZED VEGF 06-24-2010
66. 20100158914 KLOTHO BETA - The invention concerns uses of anti-KL 06-24-2010
67. 20100158856 Assays and methods using biomarkers - Methods and assays examining expression of one or more biomarkers in a mammalian tissue or cell sample are 06-24-2010
68. 20100150928 METHODS AND COMPOSITIONS RELATING TO ZPA POLYPEPTIDES 06-17-2010
69. 20100145027 Compositions and Methods for the Diagnosis and Treatment of Tumor 06-10-2010
70. 20100144732 PYRIMIDINE KINASE INHIBITORS - The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment 06-10-2010
71. 20100143351 Anti-Angiogenesis Therapy for the Treatment of Breast Cancer 06-10-2010
72. 20100137394 PYRAZOLE INHIBITORS OF WNT SIGNALING - The invention provides inhibitors of Wnt signaling that are useful as a therapeutic agents for treating 06-03-2010
73. 20100136624 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method 06-03-2010
74. 20100136580 DISHEVELED PDZ MODULATORS - The invention provides modulators of Dvl PDZ-ligand interaction, and methods of identifying and using these modulators 06-03-2010
75. 20100136005 Method of Treatment Using Humanized Anti-CD11a Antibodies 06-03-2010
76. 20100130539 IMIDAZOPYRIDINE INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where 05-27-2010
77. 20100129375 METHODS FOR INHIBITING OCULAR ANGIOGENESIS 05-27-2010
78. 20100129356 COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT 05-27-2010
79. 20100119523 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 05-13-2010
80. 20100113350 METHODS AND COMPOSITIONS FOR MODULATING PROSTASIN 05-06-2010
81. 20100111971 ANTI-NOTCH3 AGONIST ANTIBODIES AND THEIR USE IN THE TREATMENT OF NOTCH3-RELATED DISEASES 05-06-2010
82. 20100111963 METHOD FOR TREATING AGE-RELATED MACULAR DEGENERATION 05-06-2010
83. 20100111856 ZIRCONIUM-RADIOLABELED, CYSTEINE ENGINEERED ANTIBODY CONJUGATES 05-06-2010
84. 20100099101 METHODS FOR TREATING, DIAGNOSING, AND MONITORING LUPUS 04-22-2010
85. 20100098730 IMMUNOGLOBULIN VARIANTS AND USES THEREOF 04-22-2010
86. 20100098624 METHOD FOR USING CDO ANTAGONISTS TO MODULATE HEDGEHOG SIGNALING 04-22-2010
87. 20100093628 METHODS OF TREATMENT USING WISP POLYPEPTIDES 04-15-2010
88. 20100092965 GENETIC VARIATIONS ASSOCIATED WITH TUMORS 04-15-2010
89. 20100092492 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 04-15-2010
90. 20100087624 Methods for making recombinant proteins using apoptosis inhibitors 04-08-2010
91. 20100086544 COMPOSITIONS AND METHODS FOR TREATING A NEOPLASM 04-08-2010
92. 20100080810 METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES 04-01-2010
93. 20100080808 ANTI-NOTCH2 ANTIBODIES AND METHODS OF USE 04-01-2010
94. 20100080793 DcR3 polypeptide, A TNFR homolog - TNFR homolog, identified as DcR3, is provided 04-01-2010
95. 20100077495 COMPOSITIONS AND METHODS FOR THE EXPRESSION OF NUCLEIC ACIDS 03-25-2010
96. 20100069357 PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE 03-18-2010
97. 20100061996 METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR 03-11-2010
98. 20100056517 ARYLSULFONAMIDE COMPOUNDS - The invention relates generally to small molecules that mimic the biological activity of certain peptides and proteins 03-04-2010
99. 20100055099 Diagnostics and Treatments for VEGF-Independent Tumors 03-04-2010
100. 20100055095 GENETIC VARIATIONS ASSOCIATED WITH TUMORS 03-04-2010
101. 20100040634 METHODS AND COMPOSITIONS FOR MODULATING HGF/MET 02-18-2010
102. 20100035236 ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES 02-11-2010
103. 20100034837 ANTHRACYCLINE DERIVATIVE CONJUGATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR COMPOUNDS 02-11-2010
104. 20100034836 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND ALLEVIATION OF TUMOR 02-11-2010
105. 20100034821 GENETIC VARIATIONS ASSOCIATED WITH TUMORS 02-11-2010
106. 20100029491 METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE FOR TUMOR TREATMENT 02-04-2010
107. 20100028365 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER 02-04-2010
108. 20100028337 METHODS AND COMPOSITIONS FOR MODULATING HYPERSTABILIZED C-MET 02-04-2010
109. 20100021474 METHODS AND COMPOSITIONS FOR TARGETING HEPSIN 01-28-2010
110. 20100021460 Methods of Treating Autoimmune Diseases Using CD4 Antibodies 01-28-2010
111. 20100016241 METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION 01-21-2010
112. 20100015157 ANTIBODY FORMULATIONS - The present application describes antibody formulations including monoclonal antibodies formulated in histidine-acetate buffer 01-21-2010
113. 20100015135 ANTI-EPHB4 ANTIBODIES AND METHODS USING SAME 01-21-2010
114. 20100015055 PRETREATMENT OF A BIOLOGICAL SAMPLE FROM AN AUTOIMMUNE DISEASE SUBJECT 01-21-2010
115. 20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same 01-14-2010
116. 20100008910 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER 01-14-2010
117. 20100004269 5-ANILINOIMIDAZOPYRIDINES AND METHODS OF USE 01-07-2010
118. 20100003766 CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES 01-07-2010
119. 20100003239 ANTI-HEDGEHOG ANTIBODIES - their use in the detection of hedgehog expression in tissue 01-07-2010
120. 20090325962 TYROSINE DERIVATIVE - The compounds of the invention are inhibitors of alpha4 containing integrin-mediated binding to ligands such as VCAM-1 and MAdCAM 12-31-2009
121. 20090324595 CANCER PROGNOSTIC DIAGNOSTIC AND TREATMENT METHODS 12-31-2009
122. 20090318411 PURINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE 12-24-2009
123. 20090318409 PYRROLIDINE INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the 12-24-2009
124. 20090317384 Methods of using death receptor ligands and cd20 antibodies 12-24-2009
125. 20090311255 PREVENTING AUTOIMMUNE DISEASE - The present application describes a method of preventing an autoimmune disease in an asymptomatic human subject at risk 12-17-2009
126. 20090311250 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER 12-17-2009
127. 20090304701 ANTIBODIES BINDING IL-1 RELATED POLYPEPTIDES 12-10-2009
128. 20090297531 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR 12-03-2009
129. 20090297512 COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT 12-03-2009
130. 20090293137 Novel Gene Disruptions, Compositions and Methods Relating Thereto 11-26-2009
131. 20090288176 Novel Gene Disruptions, Compositions and Methods Relating Thereto 11-19-2009
132. 20090286258 ANALYSIS OF ANTIBODY DRUG CONJUGATES BY BEAD-BASED AFFINITY CAPTURE AND MASS SPECTROMETRY 11-19-2009
133. 20090285837 HER2 ANTIBODY COMPOSITION - composition comprising a main species HER2 antibody that binds to domain II of HER2 and an amino acid sequence variant 11-19-2009
134. 20090285830 ANTIBODIES TO LYMPHOTOXIN-ALPHA - The invention provides various antibodies that bind to lymphotoxin 11-19-2009
135. 20090270595 IL-1 RELATED POLYPEPTIDES - novel polypeptides having homology to the IL-1-like family of proteins and to nucleic acid molecules encoding those 10-29-2009
136. 20090269811 IL-1 RELATED POLYPEPTIDES - novel polypeptides having homology to the IL-1-like family of proteins and to nucleic acid molecules encoding those 10-29-2009
137. 20090269351 METHOD OF DIAGNOSING AND TREATING GLIOMA 10-29-2009
138. 20090269339 RESPONSES TO IMMUNIZATIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH A CD20 ANTIBODY 10-29-2009
139. 20090269338 HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF 10-29-2009
140. 20090264370 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 10-22-2009
141. 20090258025 TREATMENTS AND DIAGNOSTICS FOR CANCER, INFLAMMATORY DISORDERS AND AUTOIMMUNE DISORDERS 10-15-2009
142. 20090258013 NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES 10-15-2009
143. 20090246173 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-01-2009
144. 20090239236 GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY 09-24-2009
145. 20090226465 MACROCYCLIC DEPSIPEPTIDE ANTIBODY-DRUG CONJUGATES AND METHODS 09-10-2009
146. 20090221630 IAP INHIBITORS - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have 09-03-2009
147. 20090220504 COMBINATORIAL THERAPY - the use of VEGF antagonists and alpha5beta1 antagonists for treating cancer and inhibiting angiogenesis and/or vascular 09-03-2009
148. 20090214564 ANTI-EPHRINB2 ANTIBODIES AND METHODS USING SAME 08-27-2009
149. 20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same 08-20-2009
150. 20090208500 Method of producing antibodies with improved function 08-20-2009
151. 20090204489 BIOLOGICAL MARKERS PREDICTIVE OF RHEUMATOID ARTHRITIS RESPONSE TO B-CELL ANTAGONISTS 08-13-2009
152. 20090202546 COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF 08-13-2009
153. 20090202536 ANTIBODY-DRUG CONJUGATES AND METHODS - antibody-drug conjugate compounds of Formula I: Ab 08-13-2009
154. 20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto 08-06-2009
155. 20090192289 OMI PDZ MODULATORS - The invention provides modulators of Omi PDZ-ligand interaction, and methods of identifying and using these modulators 07-30-2009
156. 20090191215 Treatment with anti-VEGF Antibodies - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 07-30-2009
157. 20090191209 METHODS AND COMPOSITIONS FOR TARGETING POLYUBIQUITIN 07-30-2009
158. 20090191184 DcR3 polypeptide, A TNFR homolog - TNFR homolog, identified as DcR3, is provided 07-30-2009
159. 20090186812 Apo-2 ligand - novel cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is provided 07-23-2009
160. 20090186409 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR 07-23-2009
161. 20090186363 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR 07-23-2009
162. 20090186018 COMPOSITIONS AND METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS 07-23-2009
163. 20090181024 NOVEL COMPOSITION AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES 07-16-2009
164. 20090176822 PYRROLIDINE INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the 07-09-2009
165. 20090175865 CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES 07-09-2009
166. 20090175855 NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES 07-09-2009
167. 20090175854 Methods of using death receptor ligands and CD20 antibodies 07-09-2009
168. 20090169569 APO-2L receptor agonist and CPT-11 synergism 07-02-2009
169. 20090169556 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 07-02-2009
170. 20090169550 THERAPY OF RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS PATIENTS 07-02-2009
171. 20090163419 Human growth hormone aqueous formulation 06-25-2009
172. 20090162364 Apo-2 ligand - novel cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is provided 06-25-2009
173. 20090155807 C-MET MUTATIONS IN LUNG CANCER - The invention provides methods and compositions useful for detecting mutations in c-met in lung cancer cells 06-18-2009
174. 20090155259 EXTENDING TIME TO DISEASE PROGRESSION OR SURVIVAL IN CANCER PATIENTS 06-18-2009
175. 20090155247 Methods of Using Death Receptor Agonists and EGFR Inhibitors 06-18-2009
176. 20090148921 Compositions and methods for enhancing apoptosis 06-11-2009
177. 20090148457 HEPATOCYTE GROWTH FACTOR RECEPTOR ANTAGONISTS AND USES THEREOF 06-11-2009
178. 20090148448 METHODS AND COMPOSITIONS FOR MODULATING AND DETECTING WISP ACTIVITY 06-11-2009
179. 20090148435 ANTIBODY PURIFICATION BY CATION EXCHANGE CHROMATOGRAPHY 06-11-2009
180. 20090142786 SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME 06-04-2009
181. 20090142348 Novel Gene Disruptions, Compositions and Methods Relating Thereto 06-04-2009
182. 20090142259 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors 06-04-2009
183. 20090137476 Apo-2 ligand variants and uses thereof - The disclosure provides Apo-2 ligand variant polypeptides 05-28-2009
184. 20090136997 PRO1550 POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME 05-28-2009
185. 20090136492 THERAPY OF OCULAR DISORDERS - The present application describes therapy of ocular disorders using antagonists, such as antibodies, that bind to CD2 05-28-2009
186. 20090131407 TETRACYCLIC KINASE INHIBITORS - The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment 05-21-2009
187. 20090123930 METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS 05-14-2009
188. 20090098112 NOVEL ANTIBODIES - the use of VEGF antagonists and a novel anti 04-16-2009
189. 20090087428 ANTI-FC-GAMMA RIIB RECEPTOR ANTIBODY AND USES THEREFOR 04-02-2009
190. 20090087426 Methods for Treatment of Allergic Asthma 04-02-2009
191. 20090083866 TRANSGENIC ROSA26-LUCIFERASE MICE FOR BIOLUMINESCENT IMAGING 03-26-2009
192. 20090081232 METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES 03-26-2009
193. 20090081229 ANTI-PRO87299 ANTIBODIES - compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune 03-26-2009
194. 20090081223 FIXED DOSING OF HER ANTIBODIES - The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab 03-26-2009
195. 20090075317 METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION 03-19-2009
196. 20090068178 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin 03-12-2009
197. 20090068110 ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR RECEPTOR 03-12-2009
198. 20090054631 COMPOSITIONS AND METHODS FOR TREATMENT OF NON-HODGKIN'S LYMPHOMA 02-26-2009
199. 20090054624 PRO1190 POLYPEPTIDES - novel polypeptides having homology to CDO protein and to nucleic acid molecules encoding those polypeptides 02-26-2009
200. 20090053230 ANTI-OX40L ANTIBODIES AND METHODS USING SAME 02-26-2009
201. 20090053216 Treatment with Anti-VEGF Antibodies - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 02-26-2009
202. 20090048313 2-AMIDO-THIAZOLE-BASED COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF 02-19-2009
203. 20090047291 MODULATORS OF HEPATOCYTE GROWTH FACTOR ACTIVATOR 02-19-2009
204. 20090041788 Apo-2L receptor agonist and CPT-11 synergism 02-12-2009
205. 20090041749 Compositions and methods for the diagnosis and treatment of tumor 02-12-2009
206. 20090041742 HUMAN DNASE II - This invention relates to a novel human deoxyribonuclease, referred to as human DNase II 02-12-2009
207. 20090028856 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use 01-29-2009
208. 20090023602 BINDING POLYPEPTIDES WITH RESTRICTED DIVERSITY SEQUENCES 01-22-2009
209. 20090022713 ANTI-PRO87299 ANTIBODIES - compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune 01-22-2009
210. 20090012003 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 01-08-2009
211. 20090010925 ANTIBODY VARIANTS - of parent antibodies are disclosed which have one or more amino acids inserted in a hypervariable region of the parent antibody and 01-08-2009
212. 20090010924 Apoptotic Anti-IgE Antibodies - The present application relates to apoptotic anti-IgE antibodies nucleic acid encoding the same 01-08-2009
213. 20090010883 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 01-08-2009
214. 20090010881 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 01-08-2009
215. 20090004204 Assays and methods using biomarkers - Methods and assays examining expression of one or more biomarkers in a mammalian tissue or cell sample are 01-01-2009
216. 20090004189 BIOLOGICAL MARKERS PREDICTIVE OF RHEUMATOID ARTHRITIS RESPONSE TO B-CELL ANTAGONISTS 01-01-2009
217. 20080318989 Pyrimidine Kinase Inhibitors - The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment 12-25-2008
218. 20080318800 METHODS AND COMPOSITIONS FOR DETECTING AUTOIMMUNE DISORDERS 12-25-2008
219. 20080317758 Polypeptide variants with altered effector function 12-25-2008
220. 20080317753 SELECTING PATIENTS FOR THERAPY WITH A HER INHIBITOR 12-25-2008
221. 20080311134 CYSTEINE ENGINEERED ANTI-MUC16 ANTIBODIES AND ANTIBODY DRUG CONJUGATES 12-18-2008
222. 20080311107 Novel Gene Disruptions, Compositions and Methods Relating Thereto 12-18-2008
223. 20080305106 Novel Gene Disruptions, Composition and Methods Relating Thereto 12-11-2008
224. 20080299136 WNT ANTAGONISTS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF WNT-MEDIATED DISORDERS 12-04-2008
225. 20080299119 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 12-04-2008
226. 20080299117 Treatment Method - The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies of 100 mg to 200 mg 12-04-2008
227. 20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof 12-04-2008
228. 20080299115 Antibody Variants with Faster Antigen Association Rates 12-04-2008
229. 20080293121 HUMAN DNASE I HYPERACTIVE VARIANTS - amino acid sequence variants of human DNase I that have increased DNA-hydrolytic activity 11-27-2008
230. 20080292631 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 11-27-2008
231. 20080292630 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 11-27-2008
232. 20080286271 Methods and Compositions for Modulating Tweak and Fn14 Activity 11-20-2008
233. 20080280856 Fibroblast Activation Protein Inhibitor Compounds and Methods 11-13-2008
234. 20080279860 Treatment With Anti-VEGF Antibodies - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 11-13-2008
235. 20080274993 Methods and compositions for modulating vascular integrity 11-06-2008
236. 20080274506 POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION 11-06-2008
237. 20080274108 POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION 11-06-2008
238. 20080274105 POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION 11-06-2008
239. 20080267968 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-30-2008
240. 20080254024 ANTI-EPHB2 ANTIBODIES AND METHODS USING SAME 10-16-2008
241. 20080248049 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-09-2008
242. 20080248037 Dr5 Antibodies and Uses Thereof - The application provides antibodies which specifically bind to DR5 receptor 10-09-2008
243. 20080248036 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-09-2008
244. 20080247951 ANTI-ROBO4 ANTIBODIES AND USES THEREFOR - The invention provides anti-Robo4 antibodies and compositions comprising the antibodies and methods of using 10-09-2008
245. 20080242709 2-AMIDO-4-ISOXAZOLYL THIAZOLE COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF 10-02-2008
246. 20080242655 AZA-INDOLYL COMPOUNDS AND METHODS OF USE 10-02-2008
247. 20080241159 METHODS AND COMPOSITIONS FOR SELECTIVE MODULATION OF VASCULARIZATION 10-02-2008
248. 20080241148 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-02-2008
249. 20080241146 Apo-2 ligand-anti-Her-2 antibody synergism 10-02-2008
250. 20080241143 Inhibition of leukocyte adhesion - This invention relates to the inhibition of intercellular adhesion mediated by L-selectin by administering a newly 10-02-2008
251. 20080233646 Human DR4 antibodies and uses thereof - Human Death Receptor 4 antibodies are provided 09-25-2008
252. 20080227119 ELISA for VEGF - The vascular endothelial growth factor activity in a patient's bloodstream or other biological sample can serve as a diagnostic and 09-18-2008
253. 20080226629 ANTI-VEGF ANTIBODIES - Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed 09-18-2008
254. 20080226621 ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND TREATMENT OF NOTCH3-RELATED DISEASES 09-18-2008
255. 20080221014 Method of Diagnosing and Treating Glioma 09-11-2008
256. 20080220471 Vectors and Methods Using Same - vectors and to methods of using same 09-11-2008
257. 20080213837 Apo-3 ligand polypeptide - tumor necrosis factor and lymphotoxin homolog having apoptotic activity, identified as Apo-3 Ligand, is provided 09-04-2008
258. 20080213280 THERAPY OF AUTOIMMUNE DISEASE IN A PATIENT WITH AN INADEQUATE RESPONSE TO A TNF-ALPHA INHIBITOR 09-04-2008
259. 20080213268 NEUROPILIN ANTAGONISTS - Novel anti-NRP1 antibodies and variants thereof having unique structural and functional characteristics are disclosed 09-04-2008
260. 20080206243 Methods for Treating Kidney Disorders - Provided are methods of treating kidney disorders in a subject by administering an effective amount of VEGFR 08-28-2008
261. 20080200375 Angiogenesis using hepatocyte growth factor 08-21-2008
262. 20080199464 Combination Therapy with Angiogenesis Inhibitors 08-21-2008
263. 20080199423 Methods of Using Apo2l Receptor Agonists and Ink Cell Activators 08-21-2008